EvolveImmune
PrivateLast Round
Corporate Funding
Oct 31, 2024
Total Funding Raised
$92M
Momentum Score
25 /100
Company Overview
EvolveImmune Therapeutics is a biotechnology company focused on developing innovative immunotherapies to address unmet needs in oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EvolveImmune Comps
Public and private peers based on sector, stage, and business model.
EvolveImmune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Oct 31, 2024 | ||||
| Series A Extension | Dec 13, 2023 | ||||
| Series A | Jan 13, 2020 |
Key People
Founding team and executive leadership
EvolveImmune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yonjin Capital | Series A |
| Elm Street Ventures | Series A Extension, Series A |
| Pfizer Ventures | Series A Extension, Series A |
| Pfizer | Series A Extension |
| Solasta Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Presenting new data for EVOLVE T Cell engager platform at 2026 AACR Annual Meeting.
- Apr 14, 2026
Presenting new data at the 2026 AACR Annual Meeting.
EvolveImmune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EvolveImmune's valuation, stock price, and market status.
